Page last updated: 2024-11-12

deoxyartemisinin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

deoxyartemisinin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12814879
CHEMBL ID331309
SCHEMBL ID23598552
MeSH IDM0155666
PubMed CID44347173
MeSH IDM0155666

Synonyms (22)

Synonym
CHEMBL331309
artemisinin, deoxy
j59t2407wz ,
10ah-9,10b-epoxypyrano(4,3,2-jk)(2)benzoxepin-2(3h)-one, octahydro-3,6,9-trimethyl-, (3r-(3alpha,3abeta,6beta,6abeta,9beta,10aalpha,10bbeta))-
unii-j59t2407wz
72826-63-2
hydroarteannuin
deoxy artemisinin
qing hau sau iii
desoxyartemisinin
qinghaosu iii
(3r,3as,3a1r,6r,6as,9s,10as)-3,6,9-trimethyldecahydro-2h-3a1,9-epoxyoxepino(4,3,2-ij)isochromen-2-one
2-deoxyartemisinin
(3r,3as,6r,6as,9s,10as,10br)-octahydro-3,6,9-trimethyl-10ah-9,10b-epoxypyrano[4,3,2-jk][2]benzoxepin-2(3h)-one, aldrichcpr
AKOS027282466
(3r,3as,3a1r,6r,6as,9s,10as)-3,6,9-trimethyldecahydro-2h-3a1,9-epoxyoxepino[4,3,2-ij]isochromen-2-one
(1s,4s,5r,8s,9r,12s,13r)-1,5,9-trimethyl-11,14,15-trioxatetracyclo[10.2.1.04,13.08,13]pentadecan-10-one
Q27281229
SCHEMBL23598552
CS-W014047
HY-W013331
deoxyartemisinin

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"80 h(-1) with an elimination half-life (T½) of 51."( Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected mice.
Acquaah-Mensah, GK; Elfawal, MA; Rich, SM; Towler, MJ; Weathers, PJ, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID372375Antiparasitic activity against artemisinin-resistant Toxoplasma gondii STL500-10A infected in HFF cells after 72 hrs by beta-galactosidase reporter gene assay2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis.
AID151204Relative activity compared to artemisinin against Plasmodium falciparum Sierra Leone D61993Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26
Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin.
AID341602Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C42007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID341605Antimicrobial activity against Giardia duodenalis G12007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID372372Antiparasitic activity against Toxoplasma gondii ATCC 50839 infected in HFF cells after 72 hrs by beta-galactosidase reporter gene assay2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis.
AID151206Relative activity compared to artemisinin against Plasmodium falciparum Indochina W21993Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26
Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin.
AID402161Cytotoxicity against mouse EN2 cells after 72 hrs by MTT assay1997Journal of natural products, Apr, Volume: 60, Issue:4
Stereochemistry-dependent cytotoxicity of some artemisinin derivatives.
AID158855Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone)1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
Arteether, a new antimalarial drug: synthesis and antimalarial properties.
AID158684In vitro inhibitory activity against Plasmodium falciparum (Sierra leone clone)1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
Arteether, a new antimalarial drug: synthesis and antimalarial properties.
AID159028Antimalarial activity against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W22002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies.
AID572090Antimalarial activity against Plasmodium falciparum NF54 by [3H]hypoxanthine incorporation assay2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.
AID372374Antiparasitic activity against artemisinin-resistant Toxoplasma gondii KN200-6 infected in HFF cells after 72 hrs by beta-galactosidase reporter gene assay2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis.
AID341607Antimicrobial activity against Babesia divergens 42012007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID372373Antiparasitic activity against artemisinin-resistant Toxoplasma gondii KN200-1 infected in HFF cells after 72 hrs by beta-galactosidase reporter gene assay2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis.
AID341604Antimicrobial activity against Giardia duodenalis WB2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID572091Antimalarial activity against Plasmodium falciparum K1 by [3H]hypoxanthine incorporation assay2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.
AID341599Antiplasmodial activity against Plasmodium falciparum K12007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID100591Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay; Not active2003Journal of medicinal chemistry, Sep-25, Volume: 46, Issue:20
Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
AID341600Antiplasmodial activity against Plasmodium falciparum NF542007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID341598Antimicrobial activity against Neospora caninum up to 1 ug/ml2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID341603Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by axenic assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID84804Inhibitory activity against human umbilical vein endothelial cells (HUVEC) was assayed using MTT colorimetric proliferation assay2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Growth inhibition activity of thioacetal artemisinin derivatives against human umbilical vein endothelial cells.
AID341606Antimicrobial activity against Babesia divergens 1903B2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
AID341601Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB9002007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (8.70)18.7374
1990's4 (17.39)18.2507
2000's7 (30.43)29.6817
2010's10 (43.48)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.13 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index22.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]